. Among various classes of innate immune sensors, Toll-like receptors (TLRs) have a central role in initiating interleukin 12 (IL-12)-dependent immune responses to pathogens 1 . Both humans and mice share similar TLRs required for the recognition of conserved and essential bacterial and viral molecules, including the structural components of bacterial cell walls, RNA and DNA 1, 3 . However, the initial steps involved in recognition of the common protozoan parasite Toxoplasma gondii are vastly different in mice than in humans 4, 5 . In mice, recognition of the parasite is mediated by TLR11, which directly interacts with T. gondii profilin, a key molecule required for invasion of host cells by the parasite 6, 7 . T. gondii profilin is a classical pathogen-associated molecular pattern protein that is unique for T. gondii and other phylogenetically related apicomplexan parasites, including malaria and cryptosporidium 6 . Profilin is essential for T. gondii survival due to its nonredundant and essential role in regulating actin polymerization during obligate intracellular parasite entry into host cells 7 . Direct interactions between T. gondii profilin and the TLR11-TLR12 heterodimer complex lead to the induction of IL-12 and CCL2 via the adaptor MyD88 (myeloid differentiation primary response 88)-dependent signaling pathway [8] [9] [10] [11] . Both IL-12 and CCL2 are essential for host resistance to T. gondii in mice, and the lack of this cytokine and chemokine, respectively, leads to acute susceptibility to the infection 4, 12 . In marked contrast to the murine system, the initial steps for T. gondii recognition by human cells remain largely unknown due to a lack of functional genes encoding the key innate sensors TLR11 and TLR12 in the human genome 13 . TLR11 is a pseudogene, and the gene encoding TLR12, which can form a heterodimer with TLR11 (refs [8] [9] [10] ), is not present in the human genome 14 .
It is also unknown whether T. gondii profilin can be recognized by human cells. Although additional innate immune sensors, including TLR2, TLR4, NLRP1 (NOD-, LRR-and pyrin domain-containing 1) and NLRP3, can be activated by the parasite, they all have largely dispensable roles in the regulation of host defense and cytokine production 4, [15] [16] [17] . Thus, although up to one third of the world's population is infected with T. gondii and has established a long-lasting immunity to the parasite 18 , how human innate immune cells recognize the parasite remains largely unknown.
RESULTS
Toxoplasma gondii triggers human CCL2 response. Myeloid cells are sentinels of the immune system and are present in the blood and lymphoid organs and across many tissues. These cells are involved in early interactions with T. gondii 19 , and we hypothesized that they can recognize the parasite and induce protective innate immune responses. Lack of knowledge about the human cell types involved in T. gondii recognition prompted us to apply a systems biology approach with peripheral human blood cells comprising multiple hematopoietic cells. We aimed to decipher the human innate immune defense program by identifying the mediator of host defense triggered by the parasite.
An unbiased RNA-sequencing (RNA-seq) analysis of human peripheral blood cells revealed that innate responses to T. gondii were primarily characterized by the induction of chemokine expression, including that of CCL2, rather than by the induction of IL-12; this was evident from the low induction of IL12B and IL12A (Fig. 1a,b and Supplementary Fig. 1 ). These results were observed irrespective of which common laboratory T. gondii strain was used for experimental infection (RH88 or Pru).
Quantitative real-time PCR (rtPCR) analysis of CCL2 and IL12B expression confirmed the screening results and established that T. gondii infection of human blood cells leads to much greater induction of CCL2 than of IL12B (Fig. 1c) .
Although our results indicate that induction of CCL2 expression is a common effector mechanism downstream of innate parasite recognition by human cells, we also observed that there were differences in Pru and RH88 strain-mediated induction of chemokine responses ( Fig. 1 and Supplementary Fig. 1 ). This observation is most likely due to the differences in virulence factors capable of regulating chemokine response in the infected cells and the pathogenicity of the T. gondii strains [20] [21] [22] [23] . Toxoplasma gondii is a common protozoan parasite that infects up to one third of the world's population. Notably, very little is known about innate immune sensing mechanisms for this obligate intracellular parasite by human cells. Here, by applying an unbiased biochemical screening approach, we show that human monocytes recognized the presence of T. gondii infection by detecting the alarmin S100A11 protein, which is released from parasite-infected cells via caspase-1-dependent mechanisms. S100A11 induced a potent chemokine response to T. gondii by engaging its receptor RAGE, and regulated monocyte recruitment in vivo by inducing expression of the chemokine CCL2. Our experiments reveal a sensing system for T. gondii by human cells that is based on the detection of infection-mediated release of S100A11 and RAGE-dependent induction of CCL2, a crucial chemokine required for host resistance to the parasite.
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii
Alexandra
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Human peripheral blood mononuclear cells (PBMCs) secreted large amounts of CCL2, CCL22 and IL-8 protein, but not IL-12 or IL-1β (Fig. 1d) . Furthermore, we observed that the human monocyte cell line THP-1 induced high expression of CCL2 (Fig. 1g) and production of CCL2 protein in response to T. gondii, similarly to PBMCs and primary monocytes (Fig. 1e-h ). This observation suggests that the human recognition system for the parasite is distinct from the mouse recognition system, which leads to IL-12 production -1 5   CD9  LGMN  FCN1  FUCA1  LGALS2  GPNMB  CTSD  UBA52  RPLPO  CTSB  STAT1  GNAI2  EEF1A1  RPS24  ACTB  H3F3A  PTMA  RP11-1143G9.4  CYBB  FPR3  FGL2  FOGRT  LYZ  ITGB2  LIPA  CSF1R  CYP27A1  TYROBP  U91328.1  MS4A7  GRN  S100A4  NPC2  ACP5  TGFBI  LGALS1  LUZP6  RPL27  PPIA  RPL7  RPSA  CRTC2  PFON5  CD74  IFI30  AC016747.1  TPT1  RNA5SP216  COX6C  MT-TA  NACA  CCL24  IFNG  IRG1  CXCL5  IL1B  CXCL8  CCL8  CXCL1  CCL22  CCL2  GOS2  SERPINB2  RPL23  RPS19  PABPC1  CXCL3  IL1RN  CXCL9  RGS1  TXN  BCL2A1  SLC39A8  SOCS3  LAMP3  IDO1  GZMB  CXCL2  ID2  NAMPT  ATP1B3  SOD2  CTSL  MMP14  C15orf48  CD83  MT2A  CXCL11  RSAD2  CXCL10  RPL30  LGALS3  RPL4  GNB2L1  PRR13  GNB2  RPS11  ARPC2  RMRP  NPM1  HSPA8  EF4A1  RPS3  LOHA  EF5A  RPL18A + monocytes isolated from an individual donor (e,f) or an individual cell culture well with THP-1 cells (g,h). Unpaired two-tailed Student's t-test was used for statistical analysis; NS, not significant; ND, not detected.
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NAtuRE ImmuNOLOGy in response to T. gondii profilin. This notion was further supported by the lack of expression or secretion of CCL2 or IL12B expression by human monocytes directly exposed to T. gondii profilin (Fig. 2a,b) . Overall, this systems approach with human PBMCs, monocytes and an experimental THP-1 cell line infected with T. gondii reveals that the parasites triggered a potent chemokine response rather than inducing IL-12, a key signature of the mouse innate immune response to T. gondii 4 . When combined with the lack of functional genes encoding TLR11 or TLR12 in the human genome, our results establish that innate recognition of T. gondii is mediated by distinct mechanisms in human and mouse myeloid cells.
Soluble mediator triggers human CCL2 response. Toxoplasma gondii is an obligate intracellular parasite, and the growing numbers of intracellular innate immune sensors prompted us to examine whether the infection of monocytes triggers CCL2 production in a cell-intrinsic manner. THP-1 cells were infected with mCherry-expressing parasites 24 , and 12 h later the monocytes were sorted and purified as either infected (mCherry The following quantitative rtPCR analysis of CCL2 expression showed that both infected and uninfected monocytes produced similar amounts of CCL2 (Fig. 2c,d ). In the infected mCherry + cells specifically, a small but detectable induction of IL12B expression, but not secretion of IL-12p40, was observed (Fig. 2d) , as previously reported 25 . Taken together, these results suggest that the intracellular presence of T. gondii is dispensable for the induction of CCL2 by monocytes.
Host-parasite interactions lead to the presence of a third population of cells that, although not actively infected with the parasite, are exposed to parasitic molecules via contact-dependent injection of virulence factors (uninfected-injected cells) 20, 24, 26, 27 . To examine whether monocytic production of CCL2 requires cell contact with T. gondii, we monitored CCL2 expression in primary monocytes and THP-1 cells that were separated from the parasite in a transwell system. We observed that lack of direct contact between T. gondii ) and uninfected cells (Pru -and RH -). Expression of CCL2 and IL12B was measured by rtPCR. d, Protein secretion of CCL2 and IL-12p40 was measured by ELISA. e, Analysis of CCL2 and IL12B expression in THP-1 cells exposed to soluble mediators in a transwell system (TW) or by direct stimulation with cell culture supernatants collected from infected monocytes. f, Analysis of CCL2 and IL12B expression in THP-1 cells exposed to soluble mediators in a transwell system (TW) with infected fibroblasts or by direct stimulation with cell culture supernatants (sup.) collected from infected fibroblasts. Each symbol represents an individual experimental sample. n = 4 (a,b); n = 3 (c-f). Data represent five independent experiments; error bars represent mean ± s.d.
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and monocytes did not prevent induction of CCL2 expression (Fig. 2e,f) . Taken together, these results suggest that soluble mediators were responsible for CCL2 induction in response to parasite infection. This hypothesis was confirmed by induction of CCL2 expression by cell culture supernatants collected from monocytes ( Fig. 2e,f) . Moreover, supernatants from nonimmune fibroblasts Human alarmin S100A11 induces CCL2. Next, we biochemically purified a soluble mediator of CCL2 induction from cell culture supernatants of human fibroblasts infected with T. gondii. Anionexchange purification showed that CCL2-inducing fractions were rapidly separated from those inducing IL-12 production from mouse splenocytes via the TLR11-mediated signaling pathway (Fig. 3a,b) . These results were obtained by analysis of CCL2 expression in THP-1 cells. The IL12B-inducing fractions in mouse splenocytes contained T. gondii profilin that was released during infection and that stimulated cells via TLR11 ( Fig. 3b and data not shown). These experiments establish that CCL2-inducing molecules in human cells have distinct biochemical properties from T. gondii profilin-initiated, TLR11-dependent induction of IL-12 by mouse cells (Fig. 3b ). An additional purification step produced a relatively pure fraction, A4, that could induce potent CCL2 expression in THP-1 cells but not expression of IL-12p40 from mouse splenocytes (Fig. 3c) . Combined with the pilot experiments suggesting a lowmolecular-mass protein as the CCL2-inducing molecule (data not shown), mass spectrometry of the detectable low-molecular-mass protein band was subsequently performed, leading to identification of the human S100A11 protein (Fig. 3c and Supplementary Fig. 2a ). This protein belongs to a large family of small Ca 2+ -binding proteins containing two conserved EF-hand motifs that serve pleotropic cellular functions and can also function as a group of damage-associated mediators of inflammation [28] [29] [30] [31] . Sequence detection by mass spectrometry showed that S100A11 is distinct from the other S100 proteins ( Supplementary Fig. 2a and data not shown).
We next directly examined whether S100A11 was sufficient for induction of CCL2. We observed that highly purified recombinant S100A11 caused potent induction of CCL2 expression in THP-1 cells (Fig. 4a) . When several other S100 proteins were used in similar assays, we observed that only the S100A8-S100A9 complex could induce substantial CCL2 expression in the stimulated cells, albeit at a lower level when compared to S100A11 (Fig. 4a) . In addition, we compared S100A11-induced CCL2 production with lipopolysaccharide-mediated activation of the same chemokine because recombinant S100A11 was expressed in Escherichia coli. We observed that large amounts of lipopolysaccharide induced relatively low amounts of CCL2 compared to those induced by S100A11 (Fig. 4a) . Furthermore, an antibody to S100A11 completely prevented CCL2 induction mediated by S100A11, but not . a, THP-1 cells were stimulated with purified recombinant S100A11, S100A12, S100A13, S100B, S100A4, S100A7 or a mixture of S100A8 and S100A9 (S100A8/9) (all at 10 ng ml ), and CCL2 expression was analyzed by rtPCR 12 h after stimulation. In several experiments, antibody to S100A11 was added to S100A11 protein (S100A11 + anti-S100A11) or to lipopolysaccharide (LPS + anti-S100A11) for 30 min before stimulation. b, Cell culture supernatants were collected from uninfected (control), Pru-or RH88-infected human fibroblasts and were used to stimulate monocytes directly or in the presence of increasing amounts of antibody to S100A11 or the isotype-matched control antibody (IC). CCL2 expression was analyzed by rtPCR. c-g, Knockdown of S100A11 in THP-1 cells (THP-1 CRISPR_44) was revealed by immunoblot and quantitative rtPCR (c) and resulted in loss of S100A11 release and induction of CCL2 in response to RH88 (d,e) and Pru (f,g) infections. rS100A11, recombinant S100A11. h, Induction of CCL2 by S100A11 or cell culture supernatants collected from T. gondii-infected cells was prevented by adding an antibody to RAGE but not the isotype control (IC). i, Induction of CCL2 by S100A11 was partially blocked by tranilast. Data represent mean ± s.d. of assays performed in triplicate and are representative of four independent experiments.
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NAtuRE ImmuNOLOGy the induction induced by lipopolysaccharide (Fig. 4a) . Taken together, these results establish that S100A11 alone can induce CCL2 expression in human monocytes. To further examine if soluble S100A11 mediated the CCL2 response, cell culture supernatants were collected from RH88-or Pru-infected fibroblasts and incubated with control antibodies or antibodies to S100A11 before stimulation of human monocytes. We observed that blocking S100A11 prevented CCL2 induction by cell culture supernatants collected from T. gondii-infected fibroblasts (Fig. 4b) .
To examine whether S100A11 is required for CCL2 induction in response to T. gondii infection, we generated S100A11-deficient THP-1 cell lines using the CRISPR/Cas9 genome editing method. Stable S100A11 knockout THP-1-CRISP_44 cells did not express S100A11, as measured by immunoblot, rtPCR and enzyme-linked immunosorbent assay (ELISA), whereas wild-type THP-1 cells did express the protein (Fig. 4c,d,f and Supplementary Fig. 2b ). The S100A11-deficient THP-1 cells did not produce significant amounts of CCL2 when infected with RH88 or Pru strains of T. gondii (Fig. 4e,g ). Similarly, we observed that short interfering RNA (siRNA) sequences against S100A11 severely reduced CCL2 induction in T. gondii-infected cells (Supplementary Fig. 3 ). Collectively, these results reveal that S100A11 not only is sufficient for induction of the CCL2 response but also is required for this activity. S100A11 induces CCL2 via RAGE. To decipher the mechanism by which S100A11 initiates the CCL2 response, we reanalyzed the RNA-seq data to identify signaling pathways that could lead to CCL2 production. The most prominent signaling pathway was a RAGE-induced cellular response to alarmins ( Supplementary  Figs. 4 and 5 ). RAGE interacts with other S100 family members [32] [33] [34] ; this prompted us to directly examine the requirement for RAGE in S100A11-mediated induction of CCL2. We found that stimulation of THP-1 cells with purified S100A11 in the presence of an antibody to RAGE, but not the isotype-matched control antibody, prevented induction of CCL2 expression (Fig. 4h) . Similar results were obtained when monocytes were stimulated with cell culture supernatants collected from T. gondii-infected, but not control, human fibroblasts (Fig. 4h) . The presence of antibodies to RAGE abrogated induction of CCL2 by cell culture supernatants produced from infected cells (Fig. 4h) . In addition, CCL2 induction was diminished when monocytes were stimulated with S100A11 in the presence of tranilast, a small-molecule inhibitor of the V domain in RAGE, which is involved in interactions with S100 proteins 35 ( Fig. 4i) . These results reveal that RAGE is a key receptor that mediates S100A11-induced CCL2 production by monocytes.
Caspase-1 mediates S100A11 release. Identification of the human intracellular protein S100A11 as a mediator of the paracrine CCL2 response in T. gondii-infected cells raised questions regarding mechanisms regulating S100A11 release from infected cells. We first examined whether parasite invasion was required for the S100A11-mediated induction of CCL2. We observed that when T. gondii was rendered incapable of invasion due to profilin deficiency 7 , it did not induce S100A11-dependent induction of CCL2 expression ( Supplementary Fig. 6a) . Similarly, blocking parasite invasion with mycalolide B 36,37 prevented T. gondii-induced induction of CCL2 in human monocytes (Supplementary Fig. 6b ). These results prompted us to examine whether the cellular lysis ultimately caused by the parasite causes S100A11 release and induction of CCL2. Our experiments showed that whereas T. gondii infection did not change 
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the expression or abundance of S100A11 in infected or surrounding cells (Fig. 5a,b) , parasite-mediated cellular damage was required for S100A11 release. Cellular death caused by rapid freezing was not sufficient for the liberation of enough S100A11 for the induction of CCL2 ( Fig. 5c and Supplementary Fig. 2c ). In addition, we observed not only that T. gondii infection led to activation of caspase-1 (Fig. 5d ), but also that the pan-caspase inhibitor zVAD and the caspase-1 inhibitor zWEHD reduced S100A11 release and abolished CCL2 induction by supernatants collected from T. gondii-infected cells (Fig. 5d,e and Supplementary Fig. 2c ). Caspase-1 -deficient THP-1 cells also showed reduced production of CCL2 in response to T. gondii infection (data not shown). As we expected, CCL2 production by caspase-1-deficient cells was not compromised when THP-1 cells were stimulated with S100A11-containing supernatants (data not shown). Overall, these results indicate that an active cellular response to T. gondii infection by an unknown intracellular receptor leads to the caspase-1-dependent release of S100A11, which is required and sufficient for the induction of CCL2.
S100A11 regulates monocyte recruitment in vivo.
To examine the importance of S100A11 in the regulation of immunity to T. gondii in vivo, S100A11-deficient mice were generated ( Supplementary  Fig. 7 ) and infected intraperitoneally with T. gondii. We observed that a lack of S100a11 led to compromised monocyte recruitment to the site of infection (Fig. 6a,b) ; this was correlated with lower concentrations of CCL2 in infected mice than in wild type mice (Fig. 6c) . Concurrently, the lack of S100a11 had no effect on the induction of the IL-12 and interferon-γ (IFN-γ ) responses in vivo (Fig. 6c,d ).
The high concentrations of these cytokines may explain the partial role of S100A11 in host survival during intraperitoneal T. gondii and S100a11 knockout (KO) mice were infected intraperitoneally with T. gondii, and the presence of inflammatory monocytes and neutrophils at the site of infection was analyzed by flow cytometry on day 5 after infection. b, Average frequency and absolute numbers of monocytes in T. gondii-infected wild-type and S100a11 knockout mice on day 5 after infection. Data are representative of four independent experiments, each involving four to six age-and sex-matched mice. c, CCL2, IL-12p40 and IFN-γ production were measured in the peritoneal cavity on day 5 after infection by ELISA. Data are representative of three independent experiments. d, CCL2, IL-12p40 and IFN-γ production were measured in sera on day 5 after infection by ELISA. Each symbol represents an individual experimental mouse. e, Wild-type, S100a11 knockout, and caspase-1/caspase-11 double knockout (DKO) mice were infected intraperitoneally with T. gondii, and the release of S100A11 was analyzed by ELISA on day 5 after infection. Data are representative of three independent experiments. f, Survival of wild-type (filled circles) and S100a11 knockout (open circles) mice infected with T. gondii (20 cysts per mouse). Data shown are representative of four independent experiments each involving six to eight age-and sex-matched mice. Unpaired two-tailed Student's t-test (b-e) and Mantel-Cox tests (f) were used for statistical analysis, NS, not significant.
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NAtuRE ImmuNOLOGy infection (Fig. 6f) . We also observed lower concentrations of S100A11 in T. gondii-infected caspase-1-and caspase-11-deficient mice than in wild type mice, confirming that caspase-1 has a role in S100A11 release in vivo (Fig. 6e ).
Oral infection with T. gondii showed that S100A11 contributes to induction of CCL2 and migration of monocytes to the site of infection, but not to the IFN-γ -mediated response to the parasite (Supplementary Fig. 8 ). Nevertheless, S100a11 deficiency led to less intestinal pathology caused by the parasitic infection ( Supplementary Fig. 8e,f) , indicating that in addition to the protective immunity, the release of S100A11 may lead to the enhanced immunopathological response caused by T. gondii.
DISCUSSIoN
Herein, we establish a biochemical basis for the induction of the chemokine response to T. gondii infection by human cells. Our results show that infection with T. gondii leads to the release of S100A11 from infected cells. This soluble mediator is both necessary and sufficient for RAGE-dependent induction of CCL2, a major chemokine required for monocyte-mediated immunity to pathogens [38] [39] [40] [41] . The previously defined mechanisms of innate immunity to T. gondii and closely related apicomplexan parasites are chiefly mediated by TLR11-mediated recognition of profilin, an essential molecule for the parasite invasion's of host cells. TLR11-dependent innate recognition leads to rapid and selective induction of IL-12, which is required for the highly polarized T helper type 1 immunity 4 . The additional results from our and other laboratories show that TLR11 forms a heterodimer with TLR12 and detects profilin released from T. gondii within the endolysosomal compartment 4 . Despite clarification of the molecular events required for the TLR11-dependent activation of MyD88, a major question about TLR11-independent sensing of the parasite still remained. This gap in knowledge needed to be filled, because TLR11 and TLR12 immunity to T. gondii is not functional in human cells. TLR11 is encoded by a pseudogene and the gene encoding TLR12 is missing in the human genome 13 . Additional TLRs, in particular TLR2 and TLR9, as well as the NLRP1 and NLRP3 inflammasomes, are engaged by the parasite, but have a minor role in defense against T. gondii 16, 42 . Given the global distribution of T. gondii in the human population and the clinical importance of this parasite, we aimed to define innate immune sensors that could be involved in human defense against T. gondii.
A systems biology approach to define innate immune pathways based on the analysis of the effector molecules triggered by T. gondii infection, combined with biochemical screening, reveals that the human recognition system for this parasite is based on detection of the damage-associated molecule S100A11, which is released from infected cells. The human recognition system is distinct from the previously identified TLR11-mediated immune response to the parasite in mice, which depends on direct sensing of the essential T. gondii protein 4, 6 . A major downstream effector of S100A11-mediated activation of human monocytes is CCL2, a chemokine regulating monocyte recruitment to the site of infection 43 . This contrasts with the soluble effector mediators released by mouse and human cells in response to T. gondii. Mouse dendritic cells produce large amounts of IL-12, whereas the human response to T. gondii is predominantly characterized by expression of CCL2. Despite biochemical differences between mice and humans in the recognition systems for T. gondii, both human and murine immunity to T. gondii rely on sensing active infection rather than the pathogen itself. This is because TLR11 detects profilin released from infected cells but not the parasite itself 44 . Moreover, activation of TLR11 by T. gondii profilin is predominantly seen in uninfected cells 44 . Similarly, human monocytes sense S100A11 released from surrounding cells infected with the parasite. This finding may represent an innate immune mechanism insensitive to an array of T. gondii virulence factors that can interfere with host defense pathways and determine the outcome of infection in vivo 20, [45] [46] [47] . Consistent with this notion, the expression of S100A11 was not affected by parasite infection, suggesting that S100A11 is a pre-made alarmin that initiates rapid CCL2-mediated immune responses to the common intracellular parasite T. gondii.
Our in vivo results in mice suggest that the release of S100A11 from infected cells has a role in both host protection against T. gondii and immunopathology mediated by CCL2-dependent defense mechanisms. Additional studies are needed to determine whether S100A11-mediated immunity to T. gondii in humans is also primarily regulated by recruitment of monocytes to the site of infection.
Overall, our experiments reveal that human cells sense T. gondii by detecting infection-mediated release of S100A11. This alarmin engages RAGE and initiates signaling pathways leading to the induction of CCL2, a crucial chemokine required for host resistance to the parasite.
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Methods
Mice. To generate S100a11
-/-mice, exons 2 and 3 of the S100A11 gene were targeted by two single-guide RNAs (sgRNAs) using CRISPR/Cas9 technology ( Supplementary Fig. 7 ) at the Mouse Genome Editing Resource at the University of Rochester Medical Center. For genotyping, targeted alleles were detected by PCR amplification with a set of primers, S100A11 wtF (5′ -GAGGCACTGCGCTCCTCTGGCACACT -3′ ) and S100A11 wtR (5′ -CTCCTGCTACCAGCTTCCATGTCAC -3′ ), resulting in PCR products of 2.7 kb for wild-type mice and 557 bp for the S100a11 knockout allele, owing to deletion of exons 2 and 3. S100a11 knockout mice were generated on C57BL/6 background. S100a11 knockout mice of both sexes were born in Mendelian ratios and gained weight normally throughout development. Sex-and age-matched 6-to 12-week-old mice were used for experiments.
All mice were maintained in the pathogen-free animal facility at the University of Rochester School of Medicine and Dentistry. All animal experimentation was conducted in accordance with the guidelines of the University of Rochester University Committee on Animal Resources (UCAR) and the Institutional Animal Care and Use Committee (IACUC). All animal experimentation in this study was reviewed and approved by the University of Rochester UCAR and IACUC.
Human blood samples. PBMCs were isolated by Ficoll-plaque density-gradient centrifugation from heparinized peripheral blood of 20 healthy volunteers. All donors consented to sample donation consistent with the University of Rochester Institutional Review Board's recommendations. Both freshly purified PBMCs and those cryopreserved in liquid nitrogen were used for the study. Cryopreserved PBMCs were thawed in warm complete media (RPMI 1640, 10% FBS, penicillinstreptomycin, l-glutamine) in preparation for in vitro stimulation. All assays were performed in triplicate.
Human primary monocytes were isolated from PBMCs using CD14 MACS microbeads (Miltenyi) or purified as CD14
+ cells from freshly prepared PBMCs.
Cell lines. THP-1 cells (TIB-202) and Hs27 fibroblasts (RL-1634) were purchased from American Type Culture Collection.
Reagents. The following siRNA targeting human S100A11 were used: sense, 5′ -CUUCAUGAAUACAGAACUAUU-3′ , antisense, 5′ -UAGUUCUGUAUUCAUGAAGUU-3′ (CTM-370710); sense, 5′ -UGAAGAAACUGGACACCAAUU-3′ , antisense, 5′ -UUGGUGUCCAGUUUCUUCAUU-3′ (CTM-370711); sense: 5′ -CAACAGUGAUGGUCAGCUAUU-3′ , antisense, 5′ -UAGCUGACCAUCACUGUUGUU-3′ (CTM-370712); sense, 5′ -GAAGUAUGCUGGAAAGGAUUU-3′ , antisense, 5′ -AUCCUUUCCAGCAUACUUCUU-3′ (CTM-370713). Custom-made siRNA against human S100A11 and control siRNA were ordered from Dharmacon. The knockdown of S100A11 in THP-1 cells was performed by CRISPR/Cas9-guided genome editing. E-CRISP, a web application (http://www.e-crisp.org/E-CRISP/), was used to design sgRNA sequences (S100A11_44, 5′ -GCTGTCTTCCAGAAGTATGC NGG-3′ ; S100A11_20, 5′ -GGGTCCTCAGGTCCGCTTCT NGG-3′ ; S100A11_45, 5′ -GGGCTGGAGATTTTTGCCTT NGG-3′ ) cloned to lentiCRISPR v2 plasmid (Addgene, 52961) and transduced to THP-1 cells by lentivirus-mediated magnitofection (ViroMag R/L Transduction Reagent, OZ Biosciences).
Caspase-1 fluorometric assay. Caspase-1/ICE fluorometric assay kit (R&D Systems, K110-100) was used to measure caspase-1 activity in T. gondii-infected cells. All assays were performed in triplicate.
Toxoplasma gondii infections. For in vitro experiments, PBMCs, CD14
+ monocytes, THP-1 or Hs27 cells were infected with RH88 or Pru T. gondii strains at a multiplicity of infection (MOI) of 3:1 for the indicated times. In several experiments, either a pan-caspase inhibitor or a caspase-1 inhibitor was added on day 1 after infection. We observed no effect of the inhibitors on the growth of T. gondii in vitro in Hs27 cells by plaque assay. For in vivo experiments, age-and sex-matched 6-to 12-week-old wild-type and S100a11
-/-mice were intraperitoneally infected with 20 T. gondii brain cysts (ME49 strain) for the duration of the experiments. For the analysis of monocyte recruitment to the site of infection, peritoneal exudate cells were collected on day 5 after infection and analyzed by flow cytometry. CD11b (clone M1/70) and CD45 (clone 30-F11) antibodies were purchased from BD Bioscience; Ly6C (clone HK1.4) and Ly6G (clone 1A8) were purchased from eBioscience (Thermo Fisher).
Isolation of lamina propria cells was performed as follows. The small intestine was removed on day 7 after infection and carefully cleaned of the mesentery and Peyer patches. The intestine was then opened longitudinally, washed of fecal contents, cut into smaller sections and subjected to two sequential incubations in PBS with 5 mM EDTA and 1 mM DTT at 37 °C with agitation to remove epithelial cells. The solution was discarded between incubation steps and replaced. The remaining tissue was agitated in PBS and then filtered through a 100-μ m strainer. The tissue was then incubated for 30 min with gentle agitation in 0.4 mg ml -1 collagenase D and 50 mg ml -1 DNase I at 37 °C. The samples were then washed through a strainer (100 μ m).
The severity of intestinal pathology was analyzed based on the following additive scoring system [48] [49] [50] . For crypt and villi integrity: 0, normal; 1, irregular villi and crypts; 2, mildly inflamed; 3, severe villi and crypt loss; 4, complete villi and crypt loss with an intact epithelial cell layer; and 5, complete loss of villi and crypts and surface epithelium. For infiltration of inflammatory cells into the mucosa: 0, normal; 1, mild; 2, modest; and 3, severe. For infiltration of the submucosa: 0, normal; 1, mild; 2, modest; and 3, severe. For infiltration of the muscle: 0, normal; 1, mild; 2, modest; and 3, severe. These scores were added, resulting in a total scoring range of 0-14. S100A11 isolation, purification and in vitro assays. Cell culture supernatants were collected from RH88-and Pru-infected HS27 cells cultured in complete medium (RPMI 1640, 10% FBS, penicillin-streptomycin and l-glutamine). The cell culture supernatants were first filtered through a 0.22 µ m filter and then separated by a HiPrepQ chromatography column by applying a linear gradient of 0-1 M NaCl in 20 mM Tris, pH 8.0. The collected fractions were analyzed on 12% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) gels (Bio-Rad) and tested for their ability to trigger CCL2 expression in THP-1 cells. The active fractions A1-A4 were pooled and subjected to cation-exchange chromatography on a Mono S column. The active fast protein liquid chromatography fractions were analyzed by SDS-PAGE and subjected to mass spectrometry-mass spectrometry analysis. The identified S100A11 peptides are shown in Supplementary Fig. 2a .
For protein expression, the synthetic S100A11 gene (NM_005620) was prepared at Integrated DNA Technologies and inserted into the pET-17b vector (Novagen) using its NdeI and XhoI restriction sites, and then expressed in E. coli strain BL21(DE3) pLysS cells. The resulting recombinant protein was purified to homogeneity (as judged by SDS-PAGE) by a combination of anion-exchange and Sepahacryl S-100 chromatography. Lipopolysaccharide levels in the recombinant protein preparations were analyzed using the LAL Chromogenic Endotoxin Quantification kit (Thermo) per the manufacturer's instructions.
The CCL2-inducing activity of cell culture supernatants and recombinant S100A11 protein was assayed by THP-1 cells, PBMCs or CD14
+ monocytes with serial dilutions of the test sample, followed by RNA extraction and measurement of CCL2 and IL12B expression by rtPCR.
For immunofluorescence, control and T. gondii-infected cells were fixed in 4% paraformaldehyde in PBS for 4 h. Cells were permeabilized with 0.2% Triton-X in PBS, and blocked with 0.1% Triton-X with 5% normal goat serum in PBS. Permeabilized cells were incubated with rabbit polyclonal antibody to S100A11 followed by secondary Alexa Fluor 488 conjugated antibody (GE Healthcare) for 1 h at room temperature, and counterstained with 4,6-diamidino-2-phenylindole (DAPI). Slides were imaged with an inverted microscope (Leica DMi8) using a Leica × 40 objective.
Quantitative real-time PCR. Total RNA was isolated from experimental cells using a Purelink RNA mini kit (Life Technologies) and subjected to first-strand cDNA synthesis using an iScript Reverse Transcription Supermix for quantitative rtPCR (Bio-Rad). Real-time PCR was performed using Ssofast Eva Green Supermix (Bio-Rad). The relative expression of each sample was determined after normalization to the housekeeping gene GAPDH using the relative ddCt rtPCR quantification method. The following primers were used for gene expression analysis: GAPDH, 5′ -GAGCCCGCAGCCTCCCGCTT-3′ and 5′ -CCCGCGGCCATCACGCCACAG-3′ ; CCL2, 5′ -CCCCAGTCACCTGCTGTTAT-3′ and 5′ -TGGAATCCTGAACCCACTTC-3′ ; and IL12B, 5′ -AGAGGCTCTTCTGACCCCCAAG-3′ and 5′ -CTCTTGCTCTTGCCCTGGACCTG-3′ .
RNA-seq data and signaling pathway analyses. Five randomly chosen human PBMC samples (out of n = 20) were prepared for RNA-seq experiments. For each sample, PBMCs were divided into three aliquots (0.5 × 10 6 cells per sample) and were (1) left untreated, (2) infected with T. gondii Pru strain at MOI of 3, or (3) infected with T. gondii RH strain at MOI of 3. After 12 h after infection, 15 samples were subjected to RNA sequencing. Total RNA was extracted and used for library preparation according to the manufacturer's protocols. Samples were sequenced on the Illumina HiSeq 1000 with 20 × 10 6 80-bp single-read per sample. Raw reads were analyzed within the Galaxy platform, trimmed for adaptor sequence, masked for low-complexity or low-quality sequences, then mapped to the hg38 assembly of the whole human genome using TopHat v2.1.0 (default parameters) and analyzed by Cuffdiff v2.2.1 (default parameters) for differential gene expression between T. gondii-infected and uninfected samples. The results of the RNA-seq data analysis pipeline were uploaded to Ingenuity Pathway Analysis software to identify signaling pathways shown in Supplementary Figs. 4 
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Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
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Sample size
No sample size calculation was performed. The exact n values used to calculate the statistics are provided and a reasonable sample size was chosen to ensure adequate reproducibility of results.
Data exclusions No data were excluded from the analysis.
For RNAseq data, only genes with the expression values in FPKM>200 were shown. We did not show genes with the lower FPLM values due to their low levels of expression, but all data will be available and are not excluded.
Replication
Experiments were replicated several times (3-5) with reproducible results, as indicated in each figure legend.
Randomization Figure 1 : Random anonymous donors (n=5) Figure 2 : Not applicable, we tested the defined chemical compounds Figure 3 : Not applicable, we tested the defined biochemical fractions Figure 4 : Not applicable, we tested the defined chemical compounds Figure 5 : Not applicable. Figure 6 : Age-and sex-matched mice were separated as WT and S100a11 KO. Mice were co-housed to minimize the microbiota effects.
Blinding
Figures 1-5: not blinded Figure 6 : The investigator was blinded (the genotypes were not revealed prior T. gondii infection).
Reporting for specific materials, systems and methods 
Antibodies
Antibodies used S100A11 Abs: generated against highly purified recombinant S100A11 protein.
hCCL2 (Cat #14-7099-68, lot E05354_1635) and IL-12p40 (cat #14-7125-68, lot E05380-1635) ELISA kit antibodies were purchased from eBiosciences. anti-RAGE antibody (Cat #AF1179, lot GWZ0416081) and rh-RAGE/Fc reagent (Cat #1145-RG, lot #FAU0714061) were purchased from R&D Systems.
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CD11b antibodies (clone M1/70, cat # 557872, lot 5009911) were purchased from BD Bioscience. CD45 antibodies (clone 30-F11, cat # 565967, lot 8037968) were purchased from BD Bioscience; Ly6C antibodies (clone HK1.4, cat# 45-5932-82, lot E10161-1634) were purchased from eBioscience Ly6G antibodies (clone 1A8, cat # 17-9668-82, lot 4286053) were purchased from eBioscience (ThermoFisher).
Validation S100A11 Abs validated for specificity against the following control proteins: A100A1, A12, A13, A4, A7, A8, A9 proteins (no reactivity). CCL2 and IL-12p40 Abs (eBiosciences) were validated by the vendor and extensively characterized in the past by our lab. RAGE Abs: these Abs blocked RAGE-induced activation caused by a previously described unrelated RAGE-ligand (HMGB1) All the flow cytometry antibodies used are from commercial sources and have been validated by the vendors. Validation data are available on the manufacturer's website. 
Eukaryotic cell lines
Palaeontology Specimen provenance
Provide provenance information for specimens and describe permits that were obtained for the work (including the name of the issuing authority, the date of issue, and any identifying information).
Specimen deposition
Indicate where the specimens have been deposited to permit free access by other researchers. Tick this box to confirm that the raw and calibrated dates are available in the paper or in Supplementary Information.
Dating methods
Animals and other organisms
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Laboratory animals
All mice used for experiments were on a C57BL/6J genetic background and 6-12 weeks-old.
To generate S100a11-/-mice, exons 2 and 3 of the S100a11 gene were targeted by two sgRNAs using CRISPR-Cas9 technology ( Supplementary Fig. 7 ) at the Mouse Genome Editing (MGE) Resource at the University of Rochester Medical Center. Genotyping of S100a11-/-mice was performed using primers S100a11 wtF (5'-gaggcactgcgctcctctggcacact -3') and S100a11 wtR (5'-ctcctgctaccagcttccatgtcac -3') that result in PCR products of 2.7 kb for WT mice and 557 bp for the S100a11 KO allele, as a result of deletion of exons 2 and 3.
C57BL/6 mice were initially purchased from the Jackson Labs and were bred at the University of Rochester.
Wild animals
The study did not involve wild animals
Field-collected samples
The study did not involve samples collected from the field.
